Latest Articles and Analysis

Arizona's restrictive Medicaid formulary limits single-tablet HIV regimens and HCV agents post-expansion.

NASTAD's hepatitis C navigation toolkit uses peer navigators and wraparound services for people who use drugs.

HHS releases integrated Viral Hepatitis National Strategic Plan calling for a syndemic approach with HIV and STI.

Quarterly Watch covering HCV treatment access across ADAPs and Medicaid, harm reduction programs, and COVID-19 impact on care.

COVID-19 caused a 50% drop in hospital HCV screening and 72% drop in primary care settings.

Final rule allowing drug importation from Canada poses safety risks from counterfeit medications.

Evaluates pandemic's impacts on HIV, HCV, and SUD services including testing disruptions and telehealth expansion.

CANN outlines advocacy priorities for the Biden era, from 340B reform and drug pricing to HIV criminalization and health equity.